PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRIVEN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION AFTER ACUTE CORONARY SYNDROME
May 1, 2010, 00:00
10.1016/S1098-3015(10)72787-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)72787-X/fulltext
Title :
PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRIVEN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION AFTER ACUTE CORONARY SYNDROME
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72787-X&doi=10.1016/S1098-3015(10)72787-X
First page :
Section Title :
Open access? :
No
Section Order :
350